OXELTIS

OXELTIS is an independent medchem oriented service company managed by former researchers from Idenix Pharmaceuticals and located in Montpellier - France. Oxeltis is a company that delivers integrated solutions for managing and executing medicinal and fine organic chemistry projects. We run FTE programs (hit to lead optimization) with an expertise in some specialty chemistry such as macrocycles (pseudopeptides), mono & poly/oligosaccharides (sugar phosphates, iminosugars, saccharidic antigens...) nucleos(t)ides (modified nucleosides, phosphoramidites...), short peptides, linkers and PROTACs (Ligands E3 CRBN ligase library ) applied to discovery programs in oncology, antivirals and antibiotics mainly. OXELTIS client portfolio includes 40+ European and US companies...

Contract research,medicinal chemistry,nucleos(t)ides,heterocyclic,macrocyclic,phosphorus chemistry,custom synthesis,sugar phosphates,iminosugars,unnatural sugars,monosaccharides and oligosaccharides,macrocycles,antivirals,oncology,antibiotics,phosphoramidites,peptides (linear,stapled,cyclic),protacs,and pseudopeptides

Oxeltis operates in the Pharmaceutical manufacturing industry.

Oxeltis's revenue is 11m - 100m

Oxeltis has 11 - 50 employees.